Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mesa Laboratories is a diversified life sciences tools company serving highly regulated markets, including biopharmaceutical, medical device, and clinical genomics sectors. The company reported $219M in FY23 revenues with a 23% three-year CAGR and 61% gross profit margin. The presentation outlines Mesa's strategy for organic growth through commercial execution and portfolio evolution while expanding exposure to high-growth verticals.
Mesa Laboratories Gyros Protein Technologies Acquisition 2019
investor_presentationinvestor_presentation
7 Pages
investor_presentation
14 Pages
Kairos Minerals
investor_presentation
Sartorius Group
AMN Healthcare Investor Presentation 2022
investor_presentationinvestor_presentation
35 Pages
AMN Healthcare Services